Ask Warren

Access Bio

950130 · KOSDAQ · ₩950130 · 엑세스바이오

₩1,924▲ ₩4 (0.21%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩6.4M₩3.7M₩3.6M₩2.5M₩962,831₩15M₩21M₩16M
Cost of sales₩14M₩6.3M₩13M₩5.3M₩9.8M₩11M₩7.8M₩13M
Gross profit−₩7.3M−₩2.6M−₩9.1M−₩2.8M−₩8.8M₩3.5M₩14M₩3.1M
Operating income−₩16M−₩7.7M−₩15M−₩9.8M−₩14M−₩5.7M₩3.3M−₩6.1M
Net income−₩20M−₩5.3M−₩50M−₩533,605−₩2.9M−₩4.7M₩3M−₩4.8M
Net income to shareholders−₩26M−₩5.2M−₩38M−₩8M−₩7.4M−₩4.5M₩75,647−₩3.5M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩410M₩411M₩424M₩479M₩492M₩491M₩504M₩519M
Current assets₩231M₩278M₩302M₩316M₩327M₩328M₩340M₩312M
Cash and equivalents₩154M₩196M₩225M₩223M₩240M₩243M₩233M₩235M
Total liabilities₩53M₩33M₩34M₩49M₩49M₩50M₩60M₩61M
Current liabilities₩33M₩16M₩17M₩21M₩21M₩20M₩27M₩18M
Borrowings₩29M₩9.6M₩10M₩10M₩11M₩10M₩10M₩11M
Total equity₩357M₩377M₩389M₩430M₩442M₩440M₩444M₩458M
Shareholders' equity₩346M₩377M₩388M₩429M₩441M₩439M₩442M₩456M

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩913,188−₩22M−₩1.3M−₩18M−₩6.3M₩5.4M−₩4.5M−₩8.8M
Free cash flow₩913,188−₩22M−₩1.3M−₩18M−₩6.3M₩5.4M−₩4.5M−₩8.8M
Dividends paid——————₩0₩0

Consolidated where available. Amounts in won.

Also known as: Access Bio / 엑세스바이오 / 950130 / KRX:950130

Source: KRX statistical information